posted on 2013-10-14, 03:13authored bySusan L. Norris, Haley K. Holmer, Lauren A. Ogden, Brittany U. Burda, Rongwei Fu
Percentage of authors of clinical practice guidelines with a financial interest in one or more of the manufacturers of patented drugs recommended in each guideline.